Generation Bio Co.GBIONASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-9.50%
↓ 597% below average
Average (26q)
1.91%
Historical baseline
Range
High:27.72%
Low:-48.66%
Volatility
3993.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -9.50% |
| Q2 2025 | 0.92% |
| Q1 2025 | -0.88% |
| Q4 2024 | 2.69% |
| Q3 2024 | -7.93% |
| Q2 2024 | 14.32% |
| Q1 2024 | -48.66% |
| Q4 2023 | 27.72% |
| Q3 2023 | 0.14% |
| Q2 2023 | -0.76% |
| Q1 2023 | 1.82% |
| Q4 2022 | 1.96% |
| Q3 2022 | -25.29% |
| Q2 2022 | 11.00% |
| Q1 2022 | 16.97% |
| Q4 2021 | -0.65% |
| Q3 2021 | -2.94% |
| Q2 2021 | 20.81% |
| Q1 2021 | 14.53% |
| Q4 2020 | 6.96% |
| Q3 2020 | 13.76% |
| Q2 2020 | 0.46% |
| Q1 2020 | 5.21% |
| Q4 2019 | -5.32% |
| Q3 2019 | 9.89% |
| Q2 2019 | 4.42% |
| Q1 2019 | 0.00% |